What is Irritable bowel syndrome (IBS)? Irritable bowel syndrome (IBS) is a common condition that affects the digestive system, causing symptoms such as abdominal pain, bloating, gas, diarrhoea, or constipation. The exact cause of IBS is not clear, but it may be triggered by factors such as diet, stress, infection, or medicines. IBS does not…
AusTrials is pleased to have been involved in conducting the ARISE-HF Phase 3 trial which has since announced encouraging results. Applied Therapeutics, a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, has announced the topline results of the ARISE-HF Phase 3…
Indigenous peoples in high income countries are disproportionately affected by Type 2 Diabetes. Socioeconomic disadvantages and inadequate access to appropriate healthcare are important contributors. This systematic review, co-authored by Associate Professor Roy Rasalam (Principal Investigator at AusTrials Sunshine in Melbourne), investigates effective designs of primary care management of Type 2 Diabetes for Indigenous adults in…
The ever-increasing number of drugs available to treat type 2 diabetes and the complexity of patients with this condition present a constant challenge when it comes to identifying the most appropriate treatment approach. The more recent glucagon-like peptide-1 receptor agonists (GLP-1RAs) are non-insulin injectable options for the management of type 2 diabetes. Effective at improving…
